Document is current
Any future updates will be listed below
-
Authors
Ronco, Claudio
Chawla, Lakhmir
Husain-Syed, Faeq
Kellum, John A.
- License Information
-
More Information
Article History
Received: 13 October 2022
Accepted: 7 January 2023
First Online: 7 February 2023
Declarations
:
: Not applicable.
: Not applicable.
: Claudio Ronco acts as an advisory board member for ASAHI, Baxter, GE, Jafron, and Medtronic and has received speaker fees from Astute, bioMérieux, B. Braun, CytoSorbents, ESTOR, FMC, and Toray, all unrelated to the submitted work. John A. Kellum discloses inventorship on a patent application held by the Universities of Pittsburgh, and Munster, and Astute Medical (US2018/074054A1) for use of TIMP-2 and IGFBP7 in conjunction with interventions to protect the kidney. Lakhmir Chawla reports consulting fees from BioPorto Medical and Exthera Medical. Lakhmir Chawla is a board member and stockholder of Exthera Medical, Stavro Medical, and Proletariat Therapeutics. Faeq Husain-Syed declares that there are no conflict of interests.
